Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Axelar advances phase II AXL-1717 trial in lung cancer

Dec. 30, 2011

Recruitment begins in phase II SyB L-0501 trial in Japan

Dec. 30, 2011

Emergent BioSolutions advances TRU-016 into phase II for leukemia indication

Dec. 30, 2011

Phase III BTOG2 trial assesses combination therapies for advanced lung cancer

Dec. 30, 2011

New suicide gene strategy shows promise as safety switch for cell therapy

Dec. 30, 2011

U.S. study describes new radiosensitizer's mode of action

Dec. 30, 2011

Progen to switch formulation of potential best-in-class heparanase inhibitor

Dec. 29, 2011

Marina Biotech and Mirna Therapeutics enter agreement for microRNA-based drugs

Dec. 29, 2011

BiTE antibody shows promise to treat diffuse large B-cell lymphoma

Dec. 29, 2011

New European approval for Avastin

Dec. 28, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...